Neal D. Shore, MD

Neal D. Shore, MD

Episodes

Specialty:

All

Year:

All

EP. 1: Combining and Sequencing Sipuleucel-T in CRPC

May 17th 2015

EP. 2: AUA2015: Biomarkers, Enzalutamide, and ARN509

May 17th 2015

EP. 3: Reassessing Trial Endpoints for CRPC

May 17th 2015

EP. 4: Administering Radium-223 for mCRPC

May 17th 2015

EP. 5: Reducing Skeletal-Related Events in Prostate Cancer

May 17th 2015

EP. 6: Symptomatic Bone Lesions in CRPC: More Options for Treatment

May 17th 2015

EP. 7: Asymptomatic Versus Symptomatic Bone Metastases in Prostate Cancer

May 17th 2015

EP. 8: Biomarkers Indicative of Bone Lesions in Prostate Cancer

May 17th 2015

EP. 9: Bone Metastases in CRPC: Prognostic for Survival

May 17th 2015

Trending on OncLive

Ifinatamab Deruxtecan BLA Voluntarily Withdrawn in Previously Treated Extensive-Stage SCLC

Etentamig Improves Response and PFS vs Standard Therapies in Triple-Class Exposed Relapsed/Refractory Myeloma

Dr Voorhees on Eligibility Criteria for the CERVINO Trial in Multiple Myeloma

Long-Term PERSEUS Data Confirm Durable PFS Benefit With D-VRd in Transplant-Eligible Newly Diagnosed Myeloma

FDA Approves Lirafugratinib for Pretreated, Locally Advanced or Metastatic Cholangiocarcinoma